Jaap Willem Back

Title: Jaap Willem Back: Innovator in Antibody Development

Introduction

Jaap Willem Back is a notable inventor based in Vleuten, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of three patents to his name, Back's work focuses on innovative solutions for treating various medical conditions.

Latest Patents

One of Jaap Willem Back's latest patents is centered around humanized anti-CCR7 receptor antibodies. This invention provides novel humanized anti-human C-C chemokine receptor type 7 (CCR7) antibodies and compositions that include these antibodies. The applications of these antibodies are extensive, as they are useful in treating cancers where tumor cells express the CCR7 receptor. Additionally, they can be employed in the treatment of inflammatory conditions, complications arising from tissue or organ transplantations, and issues associated with fibrosis. The invention also encompasses nucleic acid molecules encoding the anti-CCR7 antibodies, cells that express these antibodies, and methods for producing them.

Career Highlights

Jaap Willem Back is currently associated with Pepmab B.V., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the realm of therapeutic antibodies.

Collaborations

Throughout his career, Back has collaborated with notable colleagues, including Ronald Boshuizen and Wouter Cornelis Puijk. These partnerships have contributed to the success of his innovative projects and the advancement of their shared goals in biotechnology.

Conclusion

Jaap Willem Back's contributions to the field of antibody development highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.